Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Alzheimer's Disease

  Free Subscription


1 Am J Alzheimers Dis Other Demen
1 Ann Intern Med
1 Brain
6 J Alzheimers Dis
1 Neurobiol Aging
1 Neurosci Lett
1 PLoS Biol
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Alzheimers Dis Other Demen

  1. WANG Y, Shi M, Hong Z, Kang J, et al
    MiR-130a-3p Has Protective Effects in Alzheimer's Disease via Targeting DAPK1.
    Am J Alzheimers Dis Other Demen. 2021;36:15333175211020572.
    PubMed         Abstract available

    Ann Intern Med

    To Alois Alzheimer, From Auguste Deter.
    Ann Intern Med. 2021;174:843.


    Three FDA advisory panel members resign over approval of Alzheimer's drug.
    BMJ. 2021;373:n1503.


  4. PATEL AG, Nehete PN, Krivoshik SR, Pei X, et al
    Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys.
    Brain. 2021 Jun 15. pii: 6297373. doi: 10.1093.
    PubMed         Abstract available

    J Alzheimers Dis

  5. SAMARA M, Levine SZ, Yoshida K, Goldberg Y, et al
    Linking the Clinical Dementia Rating Scale-Sum of Boxes, the Clinician's Interview-Based Impression Plus Caregiver Input, and the Clinical Global Impression Scale: Evidence based on Individual Participant Data from Five Randomized Clinical Trials of D
    J Alzheimers Dis. 2021 Jun 9. pii: JAD201541. doi: 10.3233/JAD-201541.
    PubMed         Abstract available

  6. KVELLO-ALME M, Brathen G, White LR, Sando SB, et al
    Time to Diagnosis in Young Onset Alzheimer's Disease: A Population-Based Study from Central Norway.
    J Alzheimers Dis. 2021 Jun 9. pii: JAD210090. doi: 10.3233/JAD-210090.
    PubMed         Abstract available

  7. DARMANTHE N, Tabatabaei-Jafari H, Cherbuin N
    Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
    J Alzheimers Dis. 2021 Jun 9. pii: JAD210092. doi: 10.3233/JAD-210092.
    PubMed         Abstract available

  8. COVATTI MALCORRA BL, Mota NB, Weissheimer J, Schilling LP, et al
    Low Speech Connectedness in Alzheimer's Disease is Associated with Poorer Semantic Memory Performance.
    J Alzheimers Dis. 2021 Jun 7. pii: JAD210134. doi: 10.3233/JAD-210134.
    PubMed         Abstract available

  9. SERRA L, D'Amelio M, Esposito S, Domenico CD, et al
    Ventral Tegmental Area Disconnection Contributes Two Years Early to Correctly Classify Patients Converted to Alzheimer's Disease: Implications for Treatment.
    J Alzheimers Dis. 2021 Jun 9. pii: JAD210171. doi: 10.3233/JAD-210171.
    PubMed         Abstract available

  10. RICHARD CHEN X, Shao Y, Sadowski MJ
    Segmented Linear Mixed Model Analysis Reveals Association of the APOEvarepsilon4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
    J Alzheimers Dis. 2021 Jun 7. pii: JAD210434. doi: 10.3233/JAD-210434.
    PubMed         Abstract available

    Neurobiol Aging

  11. TUBI MA, Kothapalli D, Hapenney M, Feingold FW, et al
    Regional relationships between CSF VEGF levels and Alzheimer's disease brain biomarkers and cognition.
    Neurobiol Aging. 2021;105:241-251.
    PubMed         Abstract available

    Neurosci Lett

  12. HAUSSMANN R, Noppes F, Brandt MD, Bauer M, et al
    Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?
    Neurosci Lett. 2021 Jun 10:136044. doi: 10.1016/j.neulet.2021.136044.
    PubMed         Abstract available

    PLoS Biol

  13. TRIUNFOL M, Gouveia FC
    What's not in the news headlines or titles of Alzheimer disease articles? #InMice.
    PLoS Biol. 2021;19:e3001260.
    PubMed         Abstract available

    PLoS One

  14. JIANG X, Howard JH Jr, Rebeck GW, Turner RS, et al
    Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer's disease.
    PLoS One. 2021;16:e0252958.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.